Planet 13 Secures Florida Approval for BHO Extraction Lab

2 min readPublished On: May 19th, 2026By

LAS VEGAS – Planet 13 Holdings Inc. announced that it has received approval from the Florida Office of Medical Marijuana Use (OMMU) for its butane hash oil (BHO) extraction facility in the state. The approval completes the final major infrastructure investment in Planet 13 Florida’s operational buildout and, for the first time, enables the company to participate in Florida’s full concentrate product category.

The road to this point was neither quick nor smooth. During the company’s Q3 2025 earnings call, analysts pressed management on the delayed timeline for the BHO lab, which had originally been penciled in for completion in late 2025. Co-CEO Robert Groesbeck acknowledged at the time that while the physical facility was on schedule, regulatory approvals introduced a variable the company couldn’t fully control. That wait is now over.

The approximately 3,465-square-foot purpose-built laboratory supports production of six BHO concentrate formats as well as live resin disposable and C-Cell vaporizer cartridges. Products are expected to reach Planet 13 Florida dispensary locations in the coming months as individual product approvals are secured.

The commercial rationale is straightforward. According to Headset market data covering the twelve months ending March 2026, Florida’s concentrate segment generated approximately $125 million in retail sales – a category in which Planet 13 Florida’s participation had previously been limited. That gap left meaningful revenue on the table in a market the company has been aggressively trying to grow.

The announcement follows a period of deliberate reinvestment in Florida operations. Earlier reporting from Planet 13’s Q3 2025 results showed the quarter represented the low point for Florida, as the company worked through the residual effects of previously disclosed flower quality issues. By October 2025, sales had already climbed 8% above the average Q3 monthly figure, as improved flower quality brought returning customers back.

The BHO facility is the capstone of that rebuild. Planet 13 had described the extraction lab as the last major infrastructure investment needed to unlock the full productivity potential of its Florida operations and drive meaningful top-line and margin expansion, a claim the company had been making since at least November 2025.

With the BHO lab now green-lit, Planet 13 Florida has a more complete operational profile than at any point since the company entered the state market. The task ahead is execution: converting regulatory approvals and infrastructure into products on shelves and margin in the income statement. For a company that has spent several quarters telling analysts the pieces were almost in place, the pieces are now in place.

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!